子宫内膜异位症保守手术后药物维持治疗的研究进展  

Research progress of drug maintenance therapy after conservative surgery for endometriosis

作　　者：张国庆[1] 张丹丹[1] Zhang Guoqing;Zhang Damian(Department of Gynecological Endoscopy,the First Affiliated Hospital of Harbin Medical University,Harbin 150001,China)

机构地区：[1]哈尔滨医科大学附属第一医院妇科腔镜科,哈尔滨150001

出　　处：《中国医药》2022年第4期634-637,共4页China Medicine

摘　　要：子宫内膜异位症是一种雌激素依赖性慢性妇科疾病,育龄女性的发病率为6%~10%,主要表现为疼痛、不孕及结节或包块等。手术是子宫内膜异位症的主要治疗方案,但术后仍面临诸多问题,如囊肿复发、疼痛及合并不孕等生育问题,临床指南指出子宫内膜异位症患者保守手术后可通过长期管理药物维持治疗。本文对子宫内膜异位症保守手术后药物维持治疗的研究进展进行综述。Endometriosis is an estrogen-dependent chronic gynecological disease, which affects 6%-10% of women in childbearing age and is mainly characterized by pain, infertility and nodules. Surgery is the main treatment for that, but there are still many problems after surgery, such as cyst recurrence, pain and urgent fertility problems in women with infertility. Clinical guidelines state that long-term drug maintenance therapy can be used after surgery. This article reviews the current research status of drug maintenance treatment for conservative surgery for endometriosis.

关 键 词：子宫内膜异位症 复发 疼痛 生育 

分 类 号：R711.71[医药卫生—妇产科学]